Not a good buy right now for an impatient buyer: price is breaking into/under near-term support (~163) with weakening momentum (MACD expanding bearish).
Despite longer-term bullish moving-average structure, short-term trend and pattern-based stats skew to further downside (model suggests negative next day/week/month).
Options positioning is moderately bullish (put/call < 1), but elevated IV suggests the market is already pricing sizable moves into earnings (2026-02-19), reducing “easy” upside at this moment.
Hedge funds have been accumulating (+222.92% QoQ), which is a supportive medium-term signal, but it’s not enough to override the current short-term technical deterioration.
Politicians/Congress: no recent congress trading data available; insiders show no significant recent trend.
Technical Analysis
Trend/momentum: MACD histogram -0.532 and negatively expanding → bearish momentum building in the near term.
RSI(6) ~35 → weak/near-oversold tone, but not a clean reversal signal yet.
Moving averages: SMA_5 > SMA_20 > SMA_200 → longer-term structure remains bullish, but near-term pullback is pressuring price.
Key levels: Support S1 ~163.232 (price ~162.76 pre-market is slightly below), next support S2 ~158.397. Resistance/pivot: pivot ~171.059; reclaiming/holding above ~171 would improve the near-term setup.
Market context: S&P 500 pre-market mildly positive (+0.12%), not providing a strong tailwind for this single-name weakness.
Volatility: IV30 ~51.11 vs historical vol ~46.23; IV percentile ~80.72 → options are relatively expensive and imply heightened expected movement (notably ahead of earnings).
Activity: today’s volume 114,363 with strong open interest (~1.98M) → active, liquid chain; however, high IV can cap risk-adjusted attractiveness for fresh upside bets.
Interpretation: options market is not screaming “panic,” but the elevated IV suggests a lot of event risk is already priced in.
Technical Summary
Sell
3
Buy
10
Positive Catalysts
AI/app push: Alibaba committing 3B yuan (~$431M) to promote the Qwen AI app during Lunar New Year could accelerate user adoption and AI ecosystem traction.
Institutional flow: hedge funds are buying, with purchase amount up ~222.92% over the last quarter.
Earnings catalyst (2026-02-19 pre-market): potential for a sentiment reset if cloud/AI monetization and profit trajectory improve.
Analyst stance remains broadly constructive overall (multiple Buys/Overweights and high price targets still on the tape).
Neutral/Negative Catalysts
raises the odds of further downside toward ~
Macro/regulatory geopolitics: U.S. review of Nvidia chip exports to China could constrain advanced compute availability and impact the broader China AI buildout (sentiment headwind for major China tech).
Financial Performance
Latest quarter: 2026/Q2.
Revenue: 34.62B, +4.85% YoY → steady top-line growth but not high acceleration.
Profitability: Net income 2.93B, -52.12% YoY; EPS 0.15, -53.12% YoY → significant earnings compression.
Margins: Gross margin 38.82, +1.09% YoY → some gross improvement, but not flowing through to net income (suggesting higher opex/capex and/or investment spending).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent rating/target trend is mixed but still net-positive:
Arete upgraded to Buy (2026-01-20) with $190 PT after a prior downgrade to Neutral (2025-12-09) with $172 PT.
Jefferies reiterated Buy; trimmed PT to $225 from $231 (2026-01-08), citing AI/cloud opportunity.
Freedom Capital downgraded to Hold from Buy (2026-01-06) but raised PT to $180, pointing to rising capex/payback uncertainty.
Wall Street pros: AI + cloud growth narrative, potential multi-quarter earnings recovery, quick-commerce losses peaking.
Wall Street cons: capex intensity/ROI debate in cloud/AI, moderated retail growth vs peers, and uncertainty on how quickly investments translate into durable net-income recovery.
Wall Street analysts forecast BABA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BABA is 203.66 USD with a low forecast of 172 USD and a high forecast of 230 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Analyst Rating
Wall Street analysts forecast BABA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BABA is 203.66 USD with a low forecast of 172 USD and a high forecast of 230 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Buy
1 Hold
0 Sell
Strong Buy
Current: 157.760
Low
172
Averages
203.66
High
230
Current: 157.760
Low
172
Averages
203.66
High
230
Arete
Neutral -> Buy
upgrade
$190
AI Analysis
2026-01-20
Reason
Arete
Price Target
$190
AI Analysis
2026-01-20
upgrade
Neutral -> Buy
Reason
Arete upgraded Alibaba to Buy from Neutral with a $190 price target.
Jefferies
Thomas Chong
Buy
downgrade
$231 -> $225
2026-01-08
Reason
Jefferies
Thomas Chong
Price Target
$231 -> $225
2026-01-08
downgrade
Buy
Reason
Jefferies analyst Thomas Chong lowered the firm's price target on Alibaba to $225 from $231 and keeps a Buy rating on the shares as part of an earnings preview. The analyst affirms Alibaba as a top pick in 2026 given its opportunities in artificial intelligence and cloud. In the December quarter, the company should continue to make solid progress in quick commerce across different metrics, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BABA
